Trump administration is removing the mainstays of NCI and the federal government’s cancer program

Peer review, registries, and evidence-based patient information take a big hit

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

How is the enterprise of cancer research doing after the first 100 days of the Trump administration?

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Paul Goldberg
Editor & Publisher
Jacquelyn Cobb
Associate Editor
Table of Contents

YOU MAY BE INTERESTED IN

How’s this for a paradox: The better cancer centers become at keeping patients alive, the more expensive cancer care becomes. This brutal tradeoff hits harder in rural areas, where the cancer burden is higher and the investigator and clinical trial representation is lower.
Paul Goldberg
Editor & Publisher
Jacquelyn Cobb
Associate Editor

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login